Inhibitors of VEGF Signaling Pathways in Glioblastoma: Is the Evidence Sufficient for Widespread Use? A European Perspective
Book:
Controversies in Neuro-Oncology
Page:
140-143
Author(s):
M. J. van den Bent
Bevacizumab for Recurrent Glioma - A Personal View
Book:
Controversies in Neuro-Oncology
Page:
133-139
Author(s):
Roger Stupp
Salvage Chemotherapy with Bevacizumab for Recurrent Anaplastic Glioma
Book:
Controversies in Neuro-Oncology
Page:
127-132
Author(s):
Marc C. Chamberlain
Role of Avastin for Treatment of Central Nervous System Radiation Necrosis
Book:
Controversies in Neuro-Oncology
Page:
117-126
Author(s):
Jing Wu and Victor A. Levin
Novel Applications for Bevacizumab and other Angiogenic Inhibitors
Book:
Controversies in Neuro-Oncology
Page:
111-116
Author(s):
Marc C. Chamberlain
Neurosurgical Implications of Avastin
Book:
Controversies in Neuro-Oncology
Page:
107-110
Author(s):
Gazanfar Rahmathulla and Michael A. Vogelbaum
Neurosurgical Implications of Bevacizumab Therapy of Malignant Gliomas
Book:
Controversies in Neuro-Oncology
Page:
100-106
Author(s):
Manish K. Aghi and Mitchel S. Berger
Assessing Radiographic Response to Bevacizumab in Patients with GBM
Book:
Controversies in Neuro-Oncology
Page:
94-99
Author(s):
John W. Henson and Bart Keogh
Imaging Responses of Bevacizumab
Book:
Controversies in Neuro-Oncology
Page:
81-93
Author(s):
R. Thind, Y. S. Mohan and T. Mikkelsen
Assessing Radiographic Response in Glioblastoma Following Avastin Treatment
Book:
Controversies in Neuro-Oncology
Page:
59-73
Author(s):
Whitney B. Pope